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Salmonella remains one of the most common causes of bacterial foodborne
gastrointestinal disease in humans. Raw eggs or food items containing undercooked
eggs are frequently identified as the source of Salmonella. Salmonella Typhimurium
contamination of table eggs most commonly occurs when they are laid in a
contaminated environment. Several control strategies, including vaccination, are widely
used to mitigate the total Salmonella load. It is unclear, however, whether live attenuated
Salmonella vaccines are efficacious over the life span of a layer hen. Live attenuated
Salmonella vaccines have been favored due to their ability to illicit a strong humoral
immune response. The lifespan of a layer hen ranges between 60 and 80 weeks
and the long term efficacy of attenuated vaccine strains has not been investigated.
In this study, commercial brown layer chicks were vaccinated at day old, 6 weeks
of age, and again at 10 weeks of age with the Bioproperties VaxsafeTM STM1 aroA
mutant vaccine. Birds were challenged at 18 weeks of age with Salmonella Typhimurium
DT9 (MLVA 03 15 08 11 550). Feces and eggs were monitored for S. Typhimurium
for 40 weeks post-infection. Birds produced a strong immune response following the
final dose which was administered intramuscularly. The serum antibody response to S.
Typhimurium DT9 infection did not differ between challenged groups. Fecal shedding
and egg contamination was highly variable and did not differ significantly between
vaccinated and unvaccinated birds that had been challenged with S. Typhimurium DT9.
Total bacterial load in feces was quantified using qPCR. No significant difference was
detected between unvaccinated and vaccinated birds after challenge.
Keywords: Salmonella Typhimurium, Salmonella vaccine, layer hen, egg contamination, persistent infection,
egg contamination
INTRODUCTION
Foodborne salmonellosis is often epidemiologically linked with the consumption of Salmonella
contaminated eggs or products containing raw or under cooked eggs (Threlfall et al., 2014).
Salmonella contamination of eggs can occur through both vertical and horizontal mechanisms.
Vertical transmission is primarily associated with Salmonella Enteritidis (S. Enteritidis) and occurs
when the bacteria infects the oviduct of a hen subsequently contaminating egg internal contents
during development (Gantois et al., 2009). Vertical transmission of other serovars including
Salmonella Typhimurium (S. Typhimurium) has been documented but to a much lesser extent
than S. Enteritidis (Keller et al., 1997; Okamura et al., 2001; Gast et al., 2011, 2013). Horizontal
contamination occurs when an egg contacts a contaminated environment (Gantois et al., 2009).
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Bacteria can then adhere to the surface of the egg and migrate into
eggshell pores (Gantois et al., 2009) or form biofilms on the shell
surface (Pande et al., 2016b) representing a risk for downstream
contamination of food items. In Australia, S. Enteritidis is not
endemic on commercial poultry farms (OzFoodNet Working
Group, 2015), thus, S. Typhimurium contamination of the layer
hen farm environment represents an important public health
issue.
The oral-fecal route of transmission is the primary
mechanism through which layer hens become infected with
S. Typhimurium on farm. Non-typhoidal Salmonella infection is
often asymptomatic for adult birds and ultimately, the bacteria
establish persistence and are continuously shed in feces (Pande
et al., 2016a). Chronic shedding over the course of the productive
life span of a layer hen can lead to a build-up of the bacteria
in the shed environment. Bacterial titres as high as 105 colony
forming units (CFU) on eggshells collected from cage front have
previously been observed (Gole et al., 2014).
Many on farm control measures such as strict farm biosecurity
as well as routine chemical decontamination of farm equipment
are widely employed to limit Salmonella contamination of eggs
(De Cort et al., 2017). Methods to limit or prevent gastrointestinal
colonization of hens are also commonly used and include the
addition of organic acids to feed and water, use of probiotics
and competitive exclusion products as well as vaccination (De
Cort et al., 2017). Vaccination in combination with other control
methods is viewed globally as an important strategy to reduce
Salmonella in poultry, ultimately mitigating the foodborne risk
of human disease (Desin et al., 2013). In the United Kingdom,
a widespread vaccination program for layer hens has been
associated with reducing human infection with S. Enteritidis
(Cogan and Humphrey, 2003).
Several live attenuated vaccines are available worldwide for
use in poultry. To date, the use of live attenuated vaccines has
been favored because they elicit both cell mediated and humoral
immune responses that provide protective immunity (Desin et al.,
2013). Deletion of the metabolic gene, aroA, in S. Typhimurium,
attenuated the virulence of this strain in mice and conferred
protection upon challenge with a wild-type strain (Hoiseth and
Stocker, 1981). Since, then several attenuated deletion mutant
S. Typhimurium strains have been developed with the aim of
reducing Salmonella shedding in poultry birds. Depending on the
mutant bacterial strain, varying degrees of effectiveness have been
observed (Barrow et al., 1990; Alderton et al., 1991; Hassan and
Curtiss, 1997; Tan et al., 1997; Groves et al., 2011). These efficacy
studies have largely focussed on the stimulation of a host immune
response and changes in prevalence of the challenge strain. For
a vaccine to be highly successful in a layer hen environment,
it should also reduce the total bacterial load shed in feces, thus
reducing the overall abundance of Salmonella in the environment
in which eggs are laid. Furthermore, few studies in layer hens have
trialed the effectiveness of live, attenuated vaccine strains over a
commercially relevant period (Hassan and Curtiss, 1997; Groves
et al., 2016).
In Australia, there is only one registered, commercially
available S. Typhimurium vaccine. This vaccine is a live
attenuated strain that was generated by disrupting the aroA
gene through the insertion of the Tn10 transposon (Alderton
et al., 1991). Vaccination of poultry with the aroA mutant has
been shown to elicit IgG, IgM, and IgA responses (Alderton
et al., 1991) and has been shown to provide protection against
wild-type challenge (Barrow et al., 1990; Alderton et al., 1991).
Mode of inoculation has, however, been shown to have an effect
on the strength of the antibody response and the protective
effect of the vaccine (Groves et al., 2016). Currently, there is
limited knowledge regarding the long-term efficacy of Salmonella
vaccines at mitigating shedding over the productive life span of
a layer hen, which can exceed 60 weeks of age. Furthermore,
the correlation between changes in fecal shedding of Salmonella
and bacterial egg contamination in vaccinated birds has not been
clearly established.
In this study, commercial brown layer chicks were vaccinated
at day old, 6 weeks, and again at 10 weeks of age with the
Bioproperties VaxsafeTM STM1 aroA mutant vaccine. Birds were
challenged at 18 weeks of age with S. Typhimurium. Feces
and eggs were processed for isolation of S. Typhimurium for
42 weeks post-infection. PCR was also used for detection and
quantification of S. Typhimurium in the feces. IgG and IgA




Fertilized Hyline Brown eggs (n = 110) were obtained from a
commercial breeding company. Parent flocks had not received
the S. Typhimurium vaccine. Eggs were fumigated with
formaldehyde to kill any bacteria present on the egg shell
surface and incubated at 38◦C over a period of 21 days. The
relative humidity was maintained at 45–55% till day 18 and then
increased to 55–65% until hatching. Chicks began hatching at
day 21 producing 62 males and 36 females. Males were separated
and included in a separate experiment. Meconium samples were
collected and tested for Salmonella using previously described
isolation methods (Gole et al., 2014). On day 1 post-hatch, female
chicks (n = 36) were divided into vaccinated and non-vaccinated
groups and housed in a positive pressure animal facility at the
Roseworthy Campus, University of Adelaide. At 12 weeks of age,
birds were separated into 4 groups [control (n = 5), vaccinated
control (n = 5), unvaccinated challenge (n = 12) and vaccinated
challenge (n = 14), and housed in separate rooms]. The
sample size for treatment groups was determined using OpenEpi
(Sullivan et al., 2009) with a 95% confidence interval and an
80% power level for detecting statistical significance between
challenged only and vaccinated and challenged treatment groups,
with α = 0.05. During rearing, samples were collected fortnightly
and processed to detect STM1 vaccine and wild-type Salmonella
by culture.
All rooms within this facility had been previously
decontaminated with SaniGuard (Chemetall, Australia). All
animal pens, cages, trays, feeders, laboratory equipment, as
well as the floor and walls of the rooms had previously been
cleaned extensively with FoamCleanS (Chemetall, Australia)
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and SaniGuard (Chemetall, Australia). All staff wore sterile,
disposable overalls, head-covers, shoe covers, masks and gloves
while working within the facility. Feed was disinfected by
fumigation with formaldehyde. Water was disinfected by the
addition of chloride tablets. Once the birds reached 60 weeks
of age, the trial was terminated. All housing procedures and
experiments were performed according to animal ethics protocol
approved by the University of Adelaide (UA) Animal Care and
Use Committee, S-2015-228.
Vaccination Schedule
The vaccination schedule used in this study was recommended
by Bioproperties and is the current practice used by Australian
egg producers (Bioproperties, personal communication). At day 1
post-hatch, birds in the vaccination treatment group received the
first vaccination. The Vaxsafe ST (S. Typhimurium strain STM1,
Batch Number STM142921B) vaccine (Bioproperties, Australia)
was diluted in 0.9% saline. A total dose of 1 × 107 CFU was
administered to each chick by dropping 25 µl of diluted vaccine
into each eye using a sterile pipette. Birds in the control, non-
vaccinated group received 25 µl of 0.9% saline into each eye.
The second dose of the STM1 vaccine was administered at
6 weeks of age. Vaccine was diluted to 5 × 106 CFU/ml in 2 L
of autoclaved tap water and provided to birds ad libitum over a
24 h period. Birds consumed a total of 700 ml of water containing
the STM1 vaccine, giving an average dosage of 109 CFU/bird.
Control, non-vaccinated birds received only autoclaved tap water
during the same period.
At 10 weeks of age, birds were given the final dose of vaccine.
STM1 was reconstituted in Marek’s diluent. Birds were inoculated
with 200 µl of STM1 (1 × 107 CFU) vaccine into the right
pectoralis muscle.
Bacterial Challenge
A S. Typhimurium definitive type (DT) 9 (MLVA 03 15 08 11
550) isolate was selected for use in this study. This isolate had
been previously isolated from layer farm and was serotyped by the
Salmonella Reference Laboratory, Institute of Veterinary Medical
Science (IMVS), Adelaide, SA, Australia. Long-term frozen stocks
of this isolate were maintained at −80◦C. Prior to use, bacteria
were resuscitated by streaking on to nutrient agar.
To generate the challenge inoculum, a single S. Typhimurium
DT9 colony was added to 5 ml of Luria Bertani (LB) broth and
incubated at 37◦C with shaking (110 rpm) for 6 h. Subsequently,
10 µl of this culture was added to 10 ml of fresh LB broth and
incubated under the same conditions overnight. The amount of
bacteria in the broth was determined by measuring the optical
density at 600 nm using a spectrophotometer. Bacteria were
diluted in LB to achieve the desired concentration. A challenge
dose of 1 × 109 CFU S. Typhimurium DT9 was selected for this
study based on results previous studies (Tan et al., 1997; Pande
et al., 2016a).
At point-of-lay (18 weeks of age), 14 hens from the vaccinated
and 12 from the challenge only groups were administered with
1 × 109 CFU S. Typhimurium DT9 in a 1.0 ml inoculum by oral
gavage. Birds in the control and vaccinated only treatment groups
received 1.0 ml of sterile LB broth. For the first 48 h post infection
(p.i.), birds were monitored twice daily.
Fecal and Egg Sampling
Feces and eggs were collected from individual birds on days 1,
3, 6, 9 12, and 15 p.i. and then weekly until week 21 p.i. when
sample collection changed to fortnightly until the end of the
experiment. The day prior to sampling, clean plastic sheets were
placed underneath individual cages to facilitate the collection
of fresh fecal material from each bird. Samples were returned
to the lab and processed immediately for the presence of S.
Typhimurium DT9 and/or STM1 using a previously described
Salmonella enrichment culture method (Gole et al., 2014). S.
Typhimurium DT9 and STM1 vaccine are easily distinguishable
from each other on xylose lysine deoxycholate (XLD) agar plates.
The STM1 vaccine strain does not produce hydrogen sulfide and
colonies appear pink when cultured on XLD.
To determine the level of contamination on the egg shell
surface, up to three eggs from each bird laid during the week, were
placed into a single, sterile, resealable bag and 10 ml/egg buffered
peptone water was added to each bag. Eggs were massaged for
90 s and the buffered peptone water was subsequently placed into
a sterile 25 ml container. Eggs were then placed into a container
filled with 70% ethanol for 90 s and air dried. Internal contents
were collected by cracking the egg into a sterile bag. Egg contents
were mixed thoroughly and then 3 ml was placed into a container
filled with 20 ml of buffered peptone water. Salmonella culture
continued as above.
Detection of Salmonella IgG and
Mucosal IgA Antibodies by ELISA
Blood samples were collected (∼1 ml) from chicks 2 weeks after
each dose of the STM1 vaccine. Following challenge with S.
Typhimurium DT9, blood was collected (∼3 ml) from each bird,
weekly and then fortnightly from week 21 p.i. All blood samples
were collected into lithium-heparinized vacutainers (Becton
Dickenson, United States). Samples were centrifuged at 2348 g for
10 min. Plasma was collected with a pipette and transferred into
a clean, microcentrifuge tube. Samples were frozen at−20◦C.
Salmonella group B antibody was quantified using the
BioChek LPS Group B chicken Salmonella antibody test
kit (Veterinary Diagnostics). The ELISA and antibody titre
calculations were conducted as per manufacturer’s instruction.
Samples were diluted 1:100 with two replicates.
The antibody avidity assay used was described previously by
Ross et al. (2000). In this experiment, plasma collected 10 days
after the final administration of the STM1 vaccine, week 3 p.i.,
and week 39 p.i. were processed in triplicate and diluted 1:100
before addition to the BioChek LPS ELISA plate. The relative
avidity was tested by adding 0, 0.5, 1.5, 2.0, 2.5, or 3.0 molar
concentrations of the chaotrophic agent, sodium thiocyanate.
Secretory IgA was measured using chicken IgA ELISA kit
(Abcam ab157691). Mucosal scrapings from the distal ileum
were collected and frozen at −80◦C until ready for use. Mucus
samples were thawed, weighed, and suspended in 4 volumes
(wt/wt) of phosphate buffered saline (PBS). Samples were mixed
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thoroughly and then centrifuged at 5,000 g for 10 min. The IgA
ELISA was conducted as per the manufacturer’s instruction with
minor modification. Mucosal samples were diluted 1:2000. The
ELISA was read at 450 nm using a ClarioStar plate reader (BMG
LabTech).
Tissue Processing for Bacteriology
At 60 weeks of age, birds were humanely euthanized by Lethabarb
(Virbac, Australia) injection following the manufacturer’s dosing
recommendation by a licensed veterinarian. Organs were
collected aseptically for culture and molecular detection of S.
Typhimurium DT9 and the STM1 vaccine strain. Biopsy punches
(5 mm2) were collected for ileum, caecum, infundibulum,
isthmus and vagina. Because of the thick basement membrane,
sections of the magnum and shell gland were cut with a sterile
scissors. Small sections of liver and spleen were also collected.
Cut samples were weighed. Tissues were homogenized with
sterilized, stainless steel beads 0.5 – 2.0 mm in 0.5 ml of 0.9%
saline. Tissues were homogenized using a Bullet Blender (Next
Advance, United States) on full speed for 5 min. If necessary, an
additional homogenization was performed to ensure the tissue
was completely disrupted. 100 µl of the tissue homogenate was
then diluted in to 900 µl of sterile 0.9% saline and diluted again
1/10. Ten microliters of each dilution was drop plated onto
XLD agar (ThermoFisher Scientific, Australia) and incubated
overnight at 37◦C. Colonies of both wild-type S. Typhimurium
and STM1 were enumerated. Strains were distinguished as
indicated above.
To enrich the sample, 100 µl of each tissue homogenate was
also placed in to 10 ml of buffered peptone water. Samples were
incubated overnight at 37◦C and then streaked out on to XLD
agar. Agar plates were incubated at 37◦C overnight and then
plates were scored for the presence of S. Typhimurium DT9 or
the STM1 vaccine.
Standard PCR Detection of S.
Typhimurium DT9 and STM1 Vaccine
Total DNA was purified from fecal and cecal samples using
the Isolate Fecal DNA kit (Bioline, Australia) with some
modifications. Briefly, 150 mg of sample was added to a safelock
microcentrifuge tube (Eppendorf, Australia) containing beads
from the kit. Lysis buffer was then added and samples were
homogenized using a Bullet Blender tissue homogenizer at
full speed for 5 min. Tubes were then incubated at 80◦C for
30 min and then cooled to room temperature. Samples were then
vortexed to mix. The remaining DNA purification procedure was
conducted as per manufacturer recommendation.
The Promega Wizard Genomic DNA kit was used to purify
DNA from tissues with some modification. Briefly, 200 µl of
tissue homogenate was combined with 600 µl nuclei lysis solution
and 17.5 µl of 20 mg/ml Proteinase K (Promega, Australia).
Samples were incubated overnight at 55◦C. The remainder of the
DNA purification procedure was performed as per manufacturer
instruction.
To detect the vaccine strain, primers (Forward 5′-3′GTTTT
AAGTGTAATTCGGGG; Reverse 5′-3′ TATGATCAAATGGT
TTCGCC) were designed to the transposon/aroA gene junction
unique to the Vaxsafe STM1 vaccine strain. This PCR reaction
generated an amplicon of 164 base pairs. To differentiate wild-
type Salmonella Typhimurium, primers were designed to the
region including the aroA gene junction which is conserved for
Salmonella strains (Forward: 5′-TCTTTTTTCATCCCCACG-3′;
Reverse: 5′-CGGTTTTACCACAAGCTAA-3′). The aroA gene
junction sequence from four S. Typhimurium isolates was aligned
to ensure primer specificity. A BLAST search was then conducted
to identify potential cross reactivity of the primers with a
non-specific target. The top 100 hits for both primers were
Salmonella sequences. Lastly, to confirm primer specificity, the
wild-type Salmonella PCR was tested against 20 different wild
type Salmonella serovars, the STM1 vaccine, and one strain
of Escherichia coli (data not shown). All wild type Salmonella
serovars generated a 182 bp amplicon (data not shown). No
amplicon was observed for the STM1 vaccine or the Escherichia
coli (data not shown).
Both wild-type and vaccine specific PCR reactions were
conducted using a total volume of 20 µl. Each reaction contained
20 ng DNA, 1x My Red Taq reaction buffer, 2 mM each forward
and reverse primer, 0.2 units of My Red Taq polymerase (Bioline,
Australia) and nuclease free water. PCR cycling conditions were
the same for both reactions and were performed using a Biorad
T100 thermocycler. The first step was an initial melt at 95◦C for
3 min. The second step included 40 cycles of 95◦C for 30 s, 60◦C
for 30 s, and 72◦C for 1:00. A final extension was done at 72◦C
for 5 min. Both standard PCR reactions had a limit of detection
of 102 CFU.
Quantitative PCR Assessment of Fecal
Samples for Wild-Type Salmonella
Using the wild-type Salmonella specific primers listed above, a
qPCR was designed to quantify the bacterial load in fecal samples
that had tested positive for S. Typhimurium DT9 using standard
PCR. The total reaction volume was 10 µL and contained 10 ng
sample DNA, 5 µL 2x Quantifast SYBR Green Master Mix,
and 1 µM of both forward and reverse primers. The qPCR
was performed with the Quantifast R© SYBR R© Green qPCR kit
(Qiagen, Australia) as per manufacturer instruction. Serial ten-
fold dilutions of S. Typhimurium DT9 spiked fecal samples were
used to generate a standard curve and determine the limit of
detection (≥1000 of Salmonella CFU/g of feces). Negative and
positive controls were included in every reaction. A two-step
qPCR cycling method was used as per (Sharma et al., 2017).
Cycling conditions included an initial melt at 95◦C for 5 min
followed by 35 cycles of 95◦C for 10 s and 58◦C 30 s using a Rotor
Gene 6000 (Corbett Research, United States). Negative samples
were assigned a limit of detection value of 1000 CFU/g feces.
Statistics
Two-way analysis of variance (ANOVA) and subsequent Tukey’s
comparisons tests were used to determine if vaccination had
an effect on prevalence (bacteriological culture) or abundance
(qPCR) of S. Typhimurium DT9 in feces over the experimental
time period. The same analysis was used to characterize the
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effect of vaccination on the prevalence of S. Typhimurium DT9
contamination of eggs collected throughout the experiment.
A D’Agostino and Pearson test of normality was conducted
on all antibody titre data. All data sets were normally distributed.
Un-paired t-tests were performed to determine if there were
significant differences in IgG titres obtained from serum collected
from vaccinated and control chicks after each dose. Two-way
ANOVA and Tukey’s comparison of the means was used to
analyze antibody titres over the experimental time course from all
treatment groups. A one-way ANOVA and Tukey’s comparison
test was used to determine if vaccination had an effect on the
concentration of secreted IgA in ileal mucosal scrapings. P-values
less than 0.05 were considered statistically significant.
RESULTS
Pre-challenge Phase
At hatch, meconium samples collected from chicks were culture
and PCR negative for Salmonella. One week after the first vaccine
dose, 10 of 12 (83.3%) fecal samples collected from the rearing
pen of vaccinated birds were positive for STM1. One week
following the second oral dose of STM1 vaccine in drinking water,
8 of 8 (100%) samples collected from the vaccinated group were
positive for STM1 vaccine. No clinical symptoms were observed
following each administration of the STM1 vaccine.
Fecal samples collected from all birds during the rearing, pre-
challenge phase of this study remained Salmonella negative.
Evidence of Disease Post-challenge
Up to 6 h post-infection (p.i.) with S. Typhimurium DT9, birds
did not exhibit any clinical symptoms of disease. After 24 h,
mucoid and blood tinged feces were observed for the challenged
only group at a higher frequency than birds that had been
vaccinated and challenged (Table 1).
All birds in the challenge only group exhibited hunching
behavior for 3 days p.i. From day 4 p.i., normal feed and water
consumption were observed and birds exhibited normal physical
activity. No hunching or reduced feed/water consumption
was observed in the vaccinated and challenged group. When
challenged, the birds were at point-of-lay, thus any effects on egg
production were difficult to identify.
Control (n = 5) and vaccinated only (n = 5) birds were not
challenged and did not exhibit any clinical signs of disease. These
birds remained negative for S. Typhimurium DT9 over the course
of the entire 60 week experiment. It should also be noted that
the STM1 vaccine strain was not cultured from either of these
treatment groups.
Shedding of S. Typhimurium DT9 and
STM1 Vaccine in Feces
Fecal shedding of S. Typhimurium DT9 was monitored using
Salmonella culture methods on days 1, 3, 6, 9, 12, and 15 p.i.
and then weekly until week 21 p.i. when sampling was performed
fortnightly until the end of the experiment. Data are presented as
the proportion of individuals with S. Typhimurium DT9 positive
feces ± the standard error of the mean. The number of fecal
samples positive for S. Typhimurium DT9 was variable for both
the challenged only and vaccinated and challenged treatment
groups (Figure 1). Significant effects of treatment (challenged
only verses vaccinated and challenged) and time were observed
(P < 0.0001; df = 34) and an interaction was observed between
both factors (time and treatment) (P = 0.018). A post hoc
comparison of the mean proportion of positive feces revealed that
vaccinated and challenged birds exhibited significantly greater
proportion of birds shedding S. Typhimurium DT9 at both weeks
4 (P < 0.01) and 17 p.i. (P < 0.05) (Figure 1).
Fecal shedding of S. Typhimurium DT9 was also monitored
by standard PCR. The limit of detection of the PCR reaction
was 102 CFU (data not shown). As with culture methods, the
proportion of fecal samples positive for S. Typhimurium DT9 was
highly variable over the experimental time course (Figure 2A).
A significant effect of time was detected (P < 0.001, df = 16) but
there were no significant differences between treatment groups
(vaccinated verses unvaccinated). At no time point was there a
significant difference in the proportion of positive fecal samples
as detected by PCR.
A wild-type Salmonella qPCR reaction was also conducted
to determine whether vaccination had an effect on the total
TABLE 1 | Frequency of mucoid or blood tinged feces in S. Typhimurium DT9 challenged birds.
Days post infection Challenged Only Vaccinated and Challenged
Appearance of feces Appearance of feces
Mucoid Blood Mucoid Blood
Frequency Percent Frequency Percent Frequency Percent Frequency Percent
1 5/12 41.7 2/12 16.7 2/14 14.3 0/14 0
2 7/12 58.3 2/12 16.7 9/14 64.3 0/14 0
3 12/12 100 8/12 66.7 4/14 28.6 0/14 0
4 11/12 91.7 8/12 66.7 3/14 21.4 0/14 0
5 6/12 50 1/12 8.3 0/14 0 0/14 0
6 4/12 33.3 0/12 0 0/14 0 0/14 0
7 0/12 0 0/12 0 0/14 0 0/14 0
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FIGURE 1 | Shedding pattern of S. Typhimurium DT9 in feces. Fecal samples were collected and tested for the presence of S. Typhimurium DT9 using standard
culture methods over a 41 week period. Data are presented as mean proportion of S. Typhimurium positive fecal samples ± the standard error. Samples collected
from challenged only (black line) as well as vaccinated and challenged (red line) birds were positive for S. Typhimurium. A two-way ANOVA test revealed significant
effects of both treatment and time (P < 0.0001). A significant interaction was also observed between both factors (P = 0.018). Multiple comparison of the means
revealed the proportion of positive feces in vaccinated and challenged birds was significantly greater proportion than challenged only birds at weeks 4 and 17 p.i.
abundance of S. Typhimurium DT9 shed in fecal samples. Peak
S. Typhimurium DT9 load in feces was observed at days 3 and
6 p.i. in both challenged only and vaccinated and challenged
groups (Figure 2B). Bacterial loads in both challenged only and
vaccinated and challenged treatment groups were significantly
reduced over time (P < 0.01, df = 16). No significant effect of
vaccination, however, was observed on the total abundance of S.
Typhimurium DT9 in fecal samples (Figure 2B).
Fecal samples collected from the vaccinated and challenged
treatment group were also monitored for the presence of the
STM1 vaccine strain using Salmonella culture methods (Table 2).
Shedding of STM1 vaccine was variable from day1 p.i. to week 3
p.i. Peak shedding was observed at day 3 p.i. when 100% of the
birds in the vaccinated and challenged group tested positive for
STM1. After week 3 p.i., STM1 vaccine was not detected in feces.
Detection of STM1 vaccine in feces was also conducted using
STM1 standard PCR. Detection of STM1 vaccine was highly
intermittent. On day 9 and week 7 p.i., one out of 14 fecal
samples tested positive for STM1. STM1 positive samples were
also observed at weeks 19 (2/14), 23 (4/14), and 39 (2/14) p.i.
Monitoring Egg Shells and Internal
Contents for S. Typhimurium DT9 and
STM1 Vaccine
Egg shells were processed for the presence of S. Typhimurium
DT9 and STM1 vaccine over the same time course as fecal
samples. Data are presented as the proportion of eggs testing
positive for S. Typhimurium DT9 by culture (Figure 3). As
with fecal samples, the proportion of egg shells positive for
S. Typhimurium DT9 was highly variable over the course of
the entire experiment. A significant effect of time was detected
(P < 0.001, df = 33) but no significant effect of treatment
was observed (P > 0.05, df = 33). The total number of S.
Typhimurium DT9 positive egg shells was, in general, lower than
fecal samples.
STM1 vaccine was not detected at any time point during the
experiment on egg shells from either treatment group.
Egg internal contents were aseptically collected and tested for
both STM1 vaccine and S. Typhimurium DT9. Over the course
of the experiment 3,297 eggs were processed and all egg internal
contents were negative for both S. Typhimurium DT9 and STM1
vaccine.
IgG Response Pre- and Post-challenge
With S. Typhimurium DT9
Serum antibodies to group B LPS were quantified from chicks
2 weeks after the first and second vaccinations and the
final administration of STM1 vaccine in the pectoralis muscle
(Figure 4A). Data are presented as mean antibody titre ± the
standard error of the mean. Antibody titres from vaccinated birds
after the first (ocular dose; day old) dose were not significantly
greater than control birds (P > 0.22, df = 13) (Figure 4A).
One week after the second (drinking water dose, 6 weeks of
age) (Figure 4B) dose group B antibodies were significantly
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FIGURE 2 | Detection and quantification of S. Typhimurium DT9 by PCR. The
prevalence of S. Typhimurium shedding was characterized using standard
PCR (A). Consistent with culture results, S. Typhimurium positive samples
were highly variable over the experimental time course. No significant
difference in the proportion of positive fecal samples was observed. The
abundance of S. Typhimurium present in fecal samples collected from both
challenged only and vaccinated and challenged birds was determined by
qPCR (B). Peak S. Typhimurium DT9 load in feces was observed at days 3
and 6 p.i. No significant difference in bacterial load was observed between the
two treatment groups.
greater than unvaccinated birds (P < 0.001, df = 13). Antibody
titres observed following both STM1 doses, however, were not
above the positive threshold for the ELISA. Following the third
inoculation into the pectoralis muscle at 10 weeks of age,
serum antibody titres in vaccinated chicks increased substantially
(Figure 4C). The mean antibody titre in vaccinated chicks was
7161.0 ± 8.15 and was significantly higher (P < 0.001, df = 13)
than the mean titre observed in control birds, 64.15 ± 8.75
(Figure 4C).
The Salmonella group B antibody response post-challenge
with S. Typhimurium DT9 was also monitored over the course
of the infection trial (Figure 4D). The peak antibody response
for challenged only and vaccinated and challenged birds occurred
at day 11 p.i. A drop was observed in both groups at week 7
p.i. but antibody titres stabilized over the remaining duration
of the trial. No significant difference (P > 0.50) was detected
between these two treatment groups. Birds in the vaccinated only
group exhibited antibody titres that remained significantly lower
(P < 0.0001) than both challenge groups. Over the course of the
experiment, titres obtained from vaccinated only birds were not
significantly different (P < 0.05) from control birds.
IgG avidity was tested 1 week after the final vaccination, at
3 weeks p.i., and at the end of the experiment at 39 weeks p.i.
Relative antibody avidity is represented as percent of negative
control. At week 3 p.i., vaccinated, vaccinated and challenged as
well as challenged only birds exhibited antibody avidity that did
not differ from values obtained from the final vaccination samples
(Figure 5A). At the 3M concentration of sodium thiocyanate,
however, antibody produced after the final vaccination exhibited
a higher avidity than the 3 week treatments (Figure 5A). At
39 weeks p.i., plasma collected from vaccinated and challenged
and challenged only birds exhibited Salmonella group B antibody
avidity that was significantly greater than the vaccinated only
birds for all concentrations except 3.0M (P < 0.001) (Figure 5B).
Detection of IgA in Intestinal Mucous
Secreted mucosal IgA (sIgA) was quantified from ileal scrapings
collected from all birds at 41 weeks p.i. Secretory IgA was
detected in all treatment groups (Figure 6). Birds challenged
with S. Typhimurium DT9 exhibited a significantly higher mean
concentration of sIgA (422.8 ± 72.6 µg IgA/mg tissue) than all
other treatment groups (P < 0.05, df = 18, R2 = 0.6494). No
significant difference in mean sIgA concentration was detected
between the control (154.7 ± 16.1 µg IgA/mg tissue), vaccinated
only (207.4 ± 34.9 µg IgA/mg tissue), or vaccinated and
challenged treatment groups (122.3± 24.9 µg IgA/mg tissue).
Detection of S. Typhimurium DT9 and
STM1 Vaccine by Culture and PCR in
Tissues
At week 40 p.i., birds were humanely euthanized and sections
of the spleen, liver, ileum, caeca, infundibulum, isthmus,
magnum, shell gland, and vagina were collected and processed
for bacteriology. A very low rate of S. Typhimurium DT9
colonization was observed (Table 3). For the ileum samples, only
one out of 12 from challenged only and one out of 14 from the
vaccinated and challenged groups were culture positive for S.
Typhimurium DT9. One of 14 caecal samples from the vaccinated
and challenge group was S. Typhimurium DT9 positive.
Tissue homogenates were subsequently enriched for
Salmonella by culturing overnight in buffered peptone water.
TABLE 2 | Proportion of fecal samples positive for the STM1 vaccine strain post challenge.
Day 1 Day 3 Day 6 Day 9 Day 12 Day 15 Week 3
STM1 positive feces 8/14 (57.1%) 14/14 (100%) 1/14 (7.1%) 4/14 (28.6%) 2/14 (14.3%) 0/14 (0%) 4/14 (28.6%)
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FIGURE 3 | Proportion of egg shells positive for S. Typhimurium DT9. Egg shells were washed with buffered peptone water which was then cultured for S.
Typhimurium DT9. Data are presented as the proportion of egg shells positive for S. Typhimurium DT9. The number of positive egg shells was variable for both
treatment groups. A significant effect of time was detected (P < 0.001). No significant difference was observed between treatment groups.
Enrichment did not substantially increase the number of S.
Typhimurium DT9 positive samples (Table 3). Post enrichment
the number of positive ileal and caecal samples from the
vaccinated and challenged group increased from 7.14% to 14.3%
and 21.4% respectively. All other samples remained negative.
The STM1 vaccine strain was detected only in one out of 14
(7.14%) caecal samples collected from birds in the vaccinated
and challenged group. Post-enrichment increased the number of
positive caecal samples to two out of 14 (14.3%). STM1 was not
detected in any other tissue samples.
PCR was also conducted on DNA purified from homogenate
samples. All tissue samples from both treatment groups were
negative for S. Typhimurium DT9 (Table 3). One caecal sample
from the vaccinated and challenged group was PCR positive for
STM1; this sample was also culture positive (data not shown).
DISCUSSION
Previous study of S. Typhimurium in layer hens has studied
the effects of infection over a limited time frame (Wales and
Davies, 2011) or to mid-lay (Pande et al., 2016a). The life span
of a commercial layer hen, however, ranges between 60 and
80 weeks. The experiments described here are unique as they
were designed to test the efficacy of a commercially available
live, attenuated S. Typhimurium vaccine using a modified vaccine
schedule recommended by the vaccine manufacturer over a
60 weeks period. The primary aim of these experiments was to
determine whether the STM1 vaccine could reduce fecal shedding
of S. Typhimurium and thus reduce egg contamination over
a commercially relevant timescale. An additional outcome of
this experimental design is the extended characterization of S.
Typhimurium infection in laying hens.
The vaccination schedule used in this study consisted of three
separate doses. The first dose was administered intraocular at day
old to mimic the course spray method used at the commercial
hatchery. The second dose was given in the drinking water when
pullets were 6 weeks of age. The final vaccination administered
intramuscularly (IM) in the pectoralis muscle at 10 weeks of
age. The IM inoculation has been shown to elicit an enhanced
immune response and extend protection (Jackson, 2012; Groves
et al., 2016). Additionally, the vaccination schedule used in the
current study is based on current industry practice and has
recently received Australian Pesticides and Veterinary Medicine
Authority approval (Bioproperties, personal communication).
Following the first two vaccinations, serum antibody
responses to the vaccine were not significantly higher than
unvaccinated birds and did not exceed the assay threshold.
Two weeks post-IM inoculation, however, a strong antibody
response was observed that was significantly higher than
control birds. These results are consistent with previous reports
demonstrating that the mode of administration of live attenuated
and inactivated vaccines has been shown to affect the strength of
the humoral immune response to vaccination (Abs El-Osta et al.,
2015; Groves et al., 2016). The avidity assay demonstrated that
antibodies produced in vaccinated animals exhibited a similar
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FIGURE 4 | Salmonella group B antibody response following vaccination Serum samples were collected and tested for group B LPS antibodies. Samples were
taken from birds 1 week after vaccination with STM1. The first STM1 dose was administered by ocular inoculation at day old (A). The second dose was
administration in drinking water at 6 weeks of age (B). The final dose was administered by IM injection into the pectoralis muscle at 10 weeks of age (C). Data are
presented as mean ± standard error of the mean. The mean antibody titre following the first (A) and second (B) doses of STM1 vaccine was not significantly
different from control unvaccinated birds and was below the positive threshold. Following IM inoculation, the mean antibody titre was significantly higher than control
(P < 0.001). The post-challenge IgG response from day 3 p.i. to week 39 p.i is shown in (D). Antibody titres from control (uninfected and non-vaccinated) (gray line)
and vaccinated only (blue line) birds were not significantly different from each other. Peak antibody titres were observed in the challenged only (black line) and
vaccinated and challenged (red line) treatment groups at day 11 p.i. Both challenged only and vaccinated and challenged birds exhibited significantly higher antibody
responses than either control or vaccinated only birds (P < 0.001). The black hashed line indicates the threshold for positive samples.
FIGURE 5 | Avidity of group B antibodies. Antibody avidity was tested by washing ELISA plates with varying concentrations of sodium thiocyanate following
incubation with test plasma. Avidity was tested at 3 weeks p.i. (A) and at week 39 (B). Avidity of final vaccination (at 10 weeks of age prior to challenge) is shown in
both A and B by the hashed line. Vaccinated birds (gray), vaccinated and challenged (red), and challenged only (black).
avidity to Salmonella group B antigens as compared to birds
challenged with the wild-type S. Typhimurium DT9 strain early
post infection. While the vaccinated only birds did not differ
significantly in avidity between early and late infection time
points, at week 39 the vaccinated and challenged and challenged
only birds exhibited significantly higher avidity, which may be
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FIGURE 6 | Comparative titres of mucosal IgA. Ileal scrapings were collected
at the end of the experiment. Secreted IgA was quantified using a chicken
specific ELISA. Mean sIgA titres ranged between 122.3 ± 24.9 µg IgA/mg
tissue and 422.8 ± 72.6 µg IgA/mg tissue. The mean sIgA titre observed in
the challenged only group (S. Typhimurium DT9; indicated as STM9) was
significantly higher than all other treatment groups (P < 0.05).
correlated with the chronicity of infection and the continuous
exposure of the bird immune system to S. Typhimurium DT9.
Secreted, intestinal mucosal IgA provides a first line defense
against oral exposure to bacterial, viral, or parasitic pathogens
(Fagarasan, 2006). Forty-two weeks post-infection, birds were
euthanized and ileal mucosal scrapings were collected and
processed for measuring secreted IgA to determine if vaccination
with STM1 had a long term effect on secretory IgA titres.
It has been previously shown that secreted mucosal IgA
was substantially (albeit not significant) higher in vaccinated
challenged birds compared to challenged only individuals (Muir
et al., 1998). In contrast, results from the present study found
that S. Typhimurium DT9 challenged birds only exhibited
significantly higher secretory IgA titres than all other treatment
groups. Serum IgA has been shown to correlate with levels of
secreted IgA in the mucosa (Rose et al., 1981; Brito et al., 1993).
It has been previously shown that serum IgA concentrations
steadily increase early during infection with S. Typhimurium
(Beal et al., 2004; Withanage et al., 2005) and stabilize over a
longer period and did not significantly change upon re-challenge
(Beal et al., 2004). It is challenging to compare previous results
with the present study, as there are substantial differences
in experimental design. During this study, low secretory IgA
levels in the vaccinated group could be attributed to the lack
of inflammatory reaction produced by the ST1 vaccine strain.
Presentation of an antigen from the intestinal lumen into
lymphoid aggregates from the payer’s patches is a prerequisite
in the stimulation of IgA response. Antigen present in the
intestine of mammals is typically taken into the gut associated
lymphoid tissues (GALT) across the specialized epithelium. Such
specialized epithelium is not so frequently found in chickens
hence, there may be variation in the cell type and mechanisms
involved in the induction of IgA response in chicken gut
(Muir et al., 2000). Further research is required to investigate
uptake of ST1 vaccine from the lumen in avian GALT. Given
the importance of the local gut immune response, focus on
developing vaccines that are effective at producing a strong
mucosal response (Gayet et al., 2017) may be the key to reducing
Salmonella colonization of the intestine and subsequent shedding
in feces. In this study, hens were euthanized at the end of the
trial and further studies are required to study secretory IgA
response in the gut of vaccinated and vaccinated challenged birds,
euthanized at periodic intervals after infection.
Birds were challenged with S. Typhimurium DT9 at 18 weeks
of age. Unvaccinated birds exhibited blood tinged mucoid feces
for several days post-challenge. Clinical signs of disease are not
typically associated with S. Typhimurium infection in adult layer
hens (Pande et al., 2016a). The birds in this study, however,
were naïve to Salmonella infection and a high challenge dose
(1 × 109 CFU) was administered. Pande et al. (2016a) noted
similar clinical signs of disease in birds challenged at 14 weeks of
age with a different isolate of S. Typhimurium DT9. The challenge
dose used in the present study was selected, in part, because
high bacterial titres are frequently detected in environmental
samples (Chousalkar et al., 2016; Gole et al., 2017). By contrast,
vaccinated birds, in this study, exhibited limited evidence of
disease. Vaccination against S. Typhimurium has been shown to
provide immunological protection against the systemic spread
of the bacteria to the spleen and liver (Hassan and Curtiss,
1994), thus limiting the severity of clinically observable disease
symptoms.
TABLE 3 | Salmonella Typhimurium DT9 detected in tissue samples collected from hens at week 40 p.i.
Challenged only Vaccinated and challenged
Organ Culture Enriched culture PCR Culture Enriched culture PCR
Spleen 0/12 0/12 0/12 0/14 0/14 0/14
Liver 0/12 0/12 0/12 0/14 0/14 0/14
Ileum 1/12 0/12 0/12 1/14 2/14 0/14
Caeca 0/12 2/12 0/12 1/14 3/14 0/14
Infundibulum 0/12 0/12 0/12 0/14 0/14 0/14
Isthmus 0/12 0/12 0/12 0/14 0/14 0/14
Magnum 0/12 0/12 0/12 0/14 0/14 0/14
Shell Gland 0/12 0/12 0/12 0/14 0/14 0/14
Vagina 0/12 0/12 0/12 0/14 0/14 0/14
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The patterns of fecal shedding were monitored for 41 weeks
post-challenge with S. Typhimurium DT9. Fecal shedding was
variable in both challenged and vaccinated and challenged
treatment groups over the course of the study. Vaccination
had no effect at reducing the number of S. Typhimurium
DT9 positive fecal samples. Overall, no significant difference
was detected between challenged and vaccinated and challenged
treatment groups. This result is in contrast to previous reports
demonstrating that birds vaccinated with either STM1 vaccine
(Alderton et al., 1991) or a S. Typhimurium rough strain did
not shed bacteria for 35 days post infection (Barrow et al.,
1990). Barrow et al. (1990) also reported that aroA mutant
S. Typhimurium F98 initially reduced fecal shedding of the
challenge strain but this effect did not persist. Tan et al. (1997)
reported that vaccination aroA mutant of S. Typhimurium
3860C also did not affect the prevalence of wild-type Salmonella
in cloacal swabs. These results were irrespective of route of
inoculation (Tan et al., 1997). A more recent report showed that
vaccination with STM1 did not have an effect on the number
of positive fecal samples over a 56 weeks period (Groves et al.,
2016).
The effect of vaccination on the abundance of the challenge
strain in fecal samples over the course of the experiment was
determined using qPCR. No significant difference in the total
load of S. Typhimurium DT9 was observed between vaccinated
and challenged and challenged only birds. Despite the high
degree of primer specificity, it should be noted that high
resolution melting of amplicons was not performed, thus the
detection of non-specific amplification, including primer dimer
cannot be precluded. Previous STM1 vaccine efficacy studies
have monitored only bacterial colonization and host immune
response to vaccination and did not characterize wild-type
Salmonella load in response to vaccination (Alderton et al.,
1991; Groves et al., 2016). Other efficacy trials investigating
other aroA mutant S. Typhimurium strains have also focussed
only on change in prevalence and not abundance of the
bacteria in fecal samples (Barrow et al., 1990; Tan et al.,
1997). Ileal and cecal sections of birds vaccinated with aroA
mutant of S. Typhimurium 3860C remained culture negative
for the challenge strain over a 12 month period but evidence
of fecal persistence of wild-type Salmonella was not investigated
(Hassan and Curtiss, 1997). In this study we used both standard
PCR for the detection and qPCR for measuring load of wild
type S. Typhimurium DT9 from feces. The standard PCR
was more sensitive than cyber green based QPCR. Hence
the standard PCR relatively ruled out false negative QPCR
results.
Eggshell contamination with S. Typhimurium DT9 was also
found to be variable over the course of the experiment. No
significant difference in the proportion of S. Typhimurium
DT9 contaminated eggs was observed between challenged only
and vaccinated and challenged treatment groups. Previous
studies investigating the effectiveness of the STM1 vaccine
have not investigated the effect of vaccination on egg shell
contamination. Arnold et al. (2014) evaluated the effectiveness
of four vaccination strategies and reported a reduction in
egg contamination with S. Typhimurium in vaccinated birds.
Vaccination with a 1 cya, 1 crp mutant S. Typhimurium
strain has been reported to completely prevent contamination
of both egg shells and egg internal contents with Salmonella
Typhimurium (Hassan and Curtiss, 1997). On production farms,
however, unless a significant reduction in the total environmental
load of Salmonella is achieved eggs will likely still acquire
Salmonella spp. on the shell surface in a highly contaminated
environment. Gole et al. (2014) reported that positive fecal, egg
belt, and dust samples were all highly associated with Salmonella
contamination of eggs. Furthermore, they demonstrated that
the odds of an eggshell becoming positive for Salmonella were
highest when a feces from a cage was also positive (Gole
et al., 2014). It should be noted that, in the present study,
no egg internal contents were found to be positive for S.
Typhimurium DT9. This result is consistent with a recent
S. Typhimurium infection trial in layer hens (Pande et al.,
2016a).
The STM1 vaccine was detected by culture following the
second administration of the vaccine in water and during the
first week post-challenge with S. Typhimurium DT9 in the
vaccinated and challenged treatment group. After week 1 post
challenge, STM1 was not cultured from fecal samples. Post-
challenge, STM1 was intermittently detected by only by PCR
in a limited number of fecal samples. Other STM1 vaccine
efficacy trials have not monitored the persistence of the vaccine
strain only its effect on the host immune response and limiting
wild-type Salmonella shedding (Alderton et al., 1991; Groves
et al., 2011, 2015). Following vaccination, another aroA mutant
vaccine, S. Typhymurium 3860C, was detected by culture for
28 days (Tan et al., 1997). In chicks, an aroA S. Enteritidis
deletion mutant colonized the liver and caeca but the total
load of the mutant strain was significantly reduced between
seven and 14 days post-infection (Methner et al., 2011). These
results may indicate that the vaccine does not establish a
persistent infection within the host. Long term persistence
of a live Salmonella vaccine in the host is important for
horizontal transfer of the vaccine strain within a flock. This
is critical in commercial poultry industry because cost remains
the major driving factor for adoption and use of new vaccines.
In the current study, the data on shedding of STM1 in feces
suggests that this vaccine has limited ability for horizontal
transfer.
At 60 weeks of age, birds were humanely euthanized
and organs were collected for bacteriology to study S.
Typhimurium DT9 persistence in vaccinated and unvaccinated
birds. Spleen and liver samples from all birds were negative for S.
Typhimurium DT9. This result is in contrast to a recent layer hen
trial which demonstrated that spleen and liver samples remained
positive for S. Typhimurium for 16 weeks post-infection (Sharma
et al., 2017). Duplicate ileum, caecal, infundibulum, isthmus,
magnum, shell gland and vagina tissue sections were collected
and treated with gentamicin to kill any bacteria adhered to the
surface. This method ensured that any bacteria cultured would
most probably be intracellular. All of these samples were negative
suggesting that positive samples likely had S. Typhimurium
DT9 in the intestinal contents. It has long been thought that
Salmonella invades and establishes a persistent infection within
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intestinal cells. It maybe, however, that the bacteria establishes
itself as part of the gut microbiome. Modulation of diet and or
the use of prebiotics and probiotics could potentially be used to
modulate the gut microbiome and thus contribute to limiting
Salmonella colonization of poultry (Pan and Yu, 2014). Further
research in this area is, however, necessary.
AUTHOR CONTRIBUTIONS
AM designed the experiments, conducted the animal trial, sample
collection, processing, conducted DNA extraction, PCR, ELISA’s,
data analysis, and wrote the manuscript. KC designed the
experiments, obtained funding, participated in conducting the
animal trial, sample collection, processing, and provided input to
the manuscript.
FUNDING
Funding for this project was obtained from Australian Eggs and
New South Wales Food Authority.
ACKNOWLEDGMENTS
The authors wish to thank Ms. Talia Moyle and Dr. Vivek Pande
for their technical assistance with these experiments.
REFERENCES
Abs El-Osta, Y., Mohotti, S., Carter, F., Kuchipudi, S., Youil, R., Underwood, G.,
et al. (2015). “Preliminary analysis of the duration of protection of Vaxsafe R© ST
vaccine against Salmonella shedding in layers,” in Proceedings of the 26th Annual
Australian Poultry Science Symposium, Sydney, NSW, 163.
Alderton, M., Fahey, K., and Coloe, P. (1991). Humoral responses
and salmonellosis protection in chickens given a vitamin-dependent
Salmonella Typhimurium mutant. Avian Dis. 35, 435–442. doi: 10.2307/15
91205
Arnold, M. E., Gosling, R. J., La Ragione, R. M., Davies, R. H., and Martelli, F.
(2014). Estimation of the impact of vaccination on faecal shedding and organ
and egg contamination for Salmonella Enteritidis, Salmonella Typhiumurium
and monophasic Salmonella Typhimurium. Avian Pathol. 43, 155–163. doi:
10.1080/03079457.2014.896990
Barrow, P., Hassan, J., Lovell, M., and Berchieri, A. (1990). Vaccination of chickens
with aroA and other mutants of Salmonella Typhimurium and S. enteritidis.
Res. Microbiol. 141, 851–853. doi: 10.1016/0923-2508(90)90120-F
Beal, R., Powers, C., Wigley, P., Barrow, P., and Smith, A. (2004). Temporal
dynamics of the cellular, humoral and cytokine responses in chickens
during primary and secondary infection with Salmonella enterica serovar
Typhimurium. Avian Pathol. 33, 25–33. doi: 10.1080/030794503100016
36282
Brito, J., Hinton, M., Stokes, C., and Pearson, C. (1993). The humoral and cell
mediated immune response of young chicks to Salmonella typhimurium and
S. kedougou. Br. Vet. J. 149, 225–234. doi: 10.1016/S0007-1935(05)80169-1
Chousalkar, K., Gole, V., Caraguel, C., and Rault, J. -L. (2016). Chasing Salmonella
Typhimurium in free range egg production system. Vet. Microbiol. 192, 67–72.
doi: 10.1016/j.vetmic.2016.06.013
Cogan, T., and Humphrey, T. (2003). The rise and fall of Salmonella Enteritidis in
the UK. J. Appl. Microbiol. 94, 114–119. doi: 10.1046/j.1365-2672.94.s1.13.x
De Cort, W., Ducatelle, R., and Van Immerseel, F. (2017). “Preharvest measures to
improve the safety of eggs,” in Producing Safe Eggs, eds S. C. Ricke and R. Gast
(Amsterdam: Elsevier), 249–280.
Desin, T. S., Köster, W., and Potter, A. A. (2013). Salmonella vaccines in poultry:
past, present and future. Expert Rev. Vaccin. 12, 87–96. doi: 10.1586/erv.12.138
Fagarasan, S. (2006). “Intestinal IgA synthesis: a primitive form of adaptive
immunity that regulates microbial communities in the gut,” in Gut-Associated
Lymphoid Tissues, eds T. Honjo and F. Melchers (Berlin: Springer), 137–153.
Gantois, I., Ducatelle, R., Pasmans, F., Haesebrouck, F., Gast, R., Humphrey, T. J.,
et al. (2009). Mechanisms of egg contamination by Salmonella Enteritidis.
FEMS Microbiol. Rev. 33, 718–738. doi: 10.1111/j.1574-6976.2008.00161.x
Gast, R. K., Guraya, R., and Guard, J. (2013). Salmonella Enteritidis deposition in
eggs after experimental infection of laying hens with different oral doses. J. Food
Prot. 76, 108–113. doi: 10.4315/0362-028X.JFP-12-268
Gast, R. K., Guraya, R., Guard, J., and Holt, P. S. (2011). The relationship between
the numbers of Salmonella Enteritidis, Salmonella Heidelberg, or Salmonella
Hadar colonizing reproductive tissues of experimentally infected laying hens
and deposition inside eggs. Avian Dis. 55, 243–247. doi: 10.1637/9540-092810-
Reg.1
Gayet, R., Bioley, G., Rochereau, N., Paul, S., and Corthésy, B. (2017). Vaccination
against Salmonella infection: the mucosal way. Microbiol. Mol. Biol. Rev.
81:e00007-17. doi: 10.1128/MMBR.00007-17
Gole, V. C., Torok, V., Sexton, M., Caraguel, C. G., and Chousalkar, K. K. (2014).
Association between indoor environmental contamination by Salmonella
enterica and contamination of eggs on layer farms. J. Clin. Microbiol. 52,
3250–3258. doi: 10.1128/JCM.00816-14
Gole, V. C., Woodhouse, R., Caraguel, C., Moyle, T., Rault, J. -L., Sexton, M.,
et al. (2017). Dynamics of Salmonella shedding and welfare of hens in
free-range egg production systems. Appl. Environ. Microbiol. 83:e03313-16.
doi: 10.1128/AEM.03313-16
Groves, P., Sharpe, S., and Muir, W. (2011). “Salmonella vaccination in layers,” in
Proceedings of the Australian Poultry Science Symposium, Sydney, NSW, 247.
Groves, P., Sharpe, S., Muir, W., Pavic, A., and Cox, J. (2016). Live and inactivated
vaccine regimens against caecal Salmonella Typhimurium colonisation in
laying hens. Aust. Vet. J. 94, 387–393. doi: 10.1111/avj.12490
Groves, P. J., Sharpe, S. M., and Cox, J. M. (2015). Response of layer and broiler
strain chickens to parenteral administration of a live Salmonella Typhimurium
vaccine. Poult. Sci. 94, 1512–1520. doi: 10.3382/ps/pev127
Hassan, J. O., and Curtiss, R. (1994). Development and evaluation of
an experimental vaccination program using a live avirulent Salmonella
Typhimurium strain to protect immunized chickens against challenge with
homologous and heterologous Salmonella serotypes. Infect. Immun. 62,
5519–5527.
Hassan, J. O., and Curtiss, R. III (1997). Efficacy of a live avirulent Salmonella
typhimurium vaccine in preventing colonization and invasion of laying hens
by Salmonella typhimurium and Salmonella enteritidis. Avian Dis. 41, 783–791.
doi: 10.2307/1592330
Hoiseth, S. K., and Stocker, B. (1981). Aromatic-dependent Salmonella
Typhimurium are non-virulent and effective as live vaccines. Nature 291,
238–239. doi: 10.1038/291238a0
Jackson, C. (2012). “The safety of parenterally administered live deletion mutant
bacterial vaccines for poultry,” in Proceedings of the World’s Poultry Conference,
Salvador, 5–9.
Keller, L. H., Schifferli, D. M., Benson, C. E., Aslam, S., and Eckroade, R. J. (1997).
Invasion of chicken reproductive tissues and forming eggs is not unique to
Salmonella Enteritidis. Avian Dis. 41, 535–539. doi: 10.2307/1592142
Methner, U., Barrow, P. A., Berndt, A., and Rychlik, I. (2011). Salmonella
Enteritidis with double deletion in phoP fliC—A potential live Salmonella
vaccine candidate with novel characteristics for use in chickens. Vaccine 29,
3248–3253. doi: 10.1016/j.vaccine.2011.02.030
Muir, W., Bryden, W., and Husband, A. (2000). Immunity, vaccination and the
avian intestinal tract. Dev. Comp. Immunol. 24, 325–342. doi: 10.1016/S0145-
305X(99)00081-6
Muir, W. I., Bryden, W. L., and Husband, A. J. (1998). Evaluation of the efficacy of
intraperitoneal immunization in reducing Salmonella typhimurium infection in
chickens. Poult. Sci. 77, 1874–1883. doi: 10.1093/ps/77.12.1874
Okamura, M., Miyamoto, T., Kamijima, Y., Tani, H., Sasai, K., and Baba, E. (2001).
Differences in abilities to colonize reproductive organs and to contaminate eggs
in intravaginally inoculated hens and in vitro adherences to vaginal explants
Frontiers in Microbiology | www.frontiersin.org 12 June 2018 | Volume 9 | Article 1380
fmicb-09-01380 June 23, 2018 Time: 16:7 # 13
McWhorter and Chousalkar Salmonella Typhimurium Vaccination in Hens
between Salmonella enteritidis and other Salmonella serovars. Avian Dis. 41,
962–971. doi: 10.2307/1592875
OzFoodNet Working Group (2015). Monitoring the incidence and causes of
diseases potentially transmitted by food in Australia: annual report of the
OzFoodNet network, 2011. Commun. Dis. Intell. Q. Rep. 39, E236–E264.
Pan, D., and Yu, Z. (2014). Intestinal microbiome of poultry and its
interaction with host and diet. Gut Microbes 5, 108–119. doi: 10.4161/gmic.
26945
Pande, V. V., Devon, R. L., Sharma, P., Mcwhorter, A. R., and Chousalkar, K. K.
(2016a). Study of Salmonella Typhimurium infection in laying hens. Front.
Microbiol. 7:203. doi: 10.3389/fmicb.2016.00203
Pande, V. V., Mcwhorter, A. R., and Chousalkar, K. K. (2016b). Salmonella enterica
isolates from layer farm environments are able to form biofilm on eggshell
surfaces. Biofouling 32, 699–710. doi: 10.1080/08927014.2016.1191068
Rose, M. E., Orlans, E., Payne, A. W., and Hesketh, P. (1981). The origin of IgA in
chicken bile: its rapid active transport from blood. Eur. J. Immunol. 11, 561–564.
doi: 10.1002/eji.1830110708
Ross, T. M., Xu, Y., Bright, R. A., and Robinson, H. L. (2000). C3d enhancement
of antibodies to hemagglutinin accelerates protection against influenza virus
challenge. Nat. Immunol. 1, 127–131. doi: 10.1038/77802
Sharma, P., Pande, V. V., Moyle, T. S., Mcwhorter, A. R., and Chousalkar, K. K.
(2017). Correlating bacterial shedding with fecal corticosterone levels and
serological responses from layer hens experimentally infected with Salmonella
Typhimurium. Vet. Res. 48:5. doi: 10.1186/s13567-017-0414-9
Sullivan, K. M., Dean, A., and Soe, M. M. (2009). On OpenEpi: a web-based
epidemiologic and statistical calculator for public health. Public Health Rep. 124,
471–474. doi: 10.1177/003335490912400320
Tan, S., Gyles, C., and Wilkie, B. (1997). Evaluation of an aroA mutant Salmonella
typhimurium vaccine in chickens using modified semisolid Rappaport
Vassiliadis medium to monitor faecal shedding. Vet. Microbiol. 54, 247–254.
doi: 10.1016/S0378-1135(96)01279-5
Threlfall, E., Wain, J., Peters, T., Lane, C., De Pinna, E., Little, C., et al. (2014). Egg-
borne infections of humans with Salmonella: not only an S. enteritidis problem.
Worlds Poult. Sci. J. 70, 15–26. doi: 10.1017/S0043933914000026
Wales, A., and Davies, R. (2011). A critical review of Salmonella Typhimurium
infection in laying hens. Avian Pathol. 40, 429–436. doi: 10.1080/03079457.2011.
606799
Withanage, G., Wigley, P., Kaiser, P., Mastroeni, P., Brooks, H., Powers, C., et al.
(2005). Cytokine and chemokine responses associated with clearance of a
primary Salmonella enterica serovar Typhimurium infection in the chicken
and in protective immunity to rechallenge. Infect. Immun. 73, 5173–5182.
doi: 10.1128/IAI.73.8.5173-5182.2005
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 McWhorter and Chousalkar. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Microbiology | www.frontiersin.org 13 June 2018 | Volume 9 | Article 1380
